The table below shows TransMedics Group, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
$24.53M
-$2.85M
-$3.44M
-$8.66M
-$18.41M
-$7.33M
Capital expenditure
$36.66M
$27.04M
$44.17M
$927.00K
$1.95M
$20.00K
Investing cash flow
-$36.66M
-$27.04M
-$44.17M
-$927.00K
$10.51M
$9.27M
Dividends paid
-
-
-
-
TMDX operating cash flow (10-K history)
TransMedics Group, Inc. reported operating cash flow of $192.84M for fiscal year 2025. That is up 295.1% from $48.80M in fiscal 2024. Over the 8 fiscal years shown, operating cash flow grew from -$25.98M (FY 2018) to $192.84M. Figures come from the company's audited annual reports as filed with the SEC.